STATE STREET CORP - SINOVAC BIOTECH LTD ownership

SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 31 filers reported holding SINOVAC BIOTECH LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of SINOVAC BIOTECH LTD
ValueSharesWeighting
Q3 2023$1,040,8610.0%160,8750.0%0.00%
Q2 2023$1,040,861
-0.0%
160,8750.0%0.00%
Q3 2022$1,041,0000.0%160,8750.0%0.00%
Q2 2022$1,041,000
-42.9%
160,875
-42.9%
0.00%
Q4 2021$1,822,0000.0%281,6400.0%0.00%
Q3 2021$1,822,0000.0%281,6400.0%0.00%
Q2 2021$1,822,0000.0%281,6400.0%0.00%
Q1 2021$1,822,000
+75.0%
281,640
+75.1%
0.00%
Q4 2020$1,041,0000.0%160,8750.0%0.00%
Q3 2020$1,041,0000.0%160,8750.0%0.00%
Q2 2020$1,041,0000.0%160,8750.0%0.00%
Q1 2020$1,041,0000.0%160,8750.0%0.00%
Q4 2019$1,041,0000.0%160,8750.0%0.00%
Q3 2019$1,041,0000.0%160,8750.0%0.00%
Q2 2019$1,041,0000.0%160,8750.0%0.00%
Q1 2019$1,041,000
+6.0%
160,875
+13.7%
0.00%
Q4 2018$982,000
+4.1%
141,512
+15.3%
0.00%
Q3 2018$943,000
-5.8%
122,721
-8.5%
0.00%
Q2 2018$1,001,000
-14.6%
134,123
-1.5%
0.00%
Q1 2018$1,172,000
+68.6%
136,169
+54.3%
0.00%
Q4 2017$695,000
+25.9%
88,254
+12.7%
0.00%
Q3 2017$552,000
+65.8%
78,336
+59.0%
0.00%
Q2 2017$333,000
+40.5%
49,281
+18.5%
0.00%
Q1 2017$237,000
-5.2%
41,570
-1.8%
0.00%
Q4 2016$250,000
+15.7%
42,325
+15.3%
0.00%
Q3 2016$216,000
+116.0%
36,718
+117.1%
0.00%
Q2 2016$100,00016,9120.00%
Other shareholders
SINOVAC BIOTECH LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Orbimed Advisors 2,718,735$340,500,0006.32%
Vivo Capital, LLC 5,900,000$38,173,0004.21%
Neumann Advisory Hong Kong Ltd 315,586$2,0420.72%
Yorktown Management & Research Co Inc 74,893$485,0000.63%
Skandinaviska Enskilda Banken AB (publ) 40,000$259,0000.00%
Renaissance Technologies 2,375,841$1,537,0000.00%
WELLS FARGO & COMPANY/MN 1,687$11,0000.00%
NORTHERN TRUST CORP 13,787$55,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 412$27,0000.00%
View complete list of SINOVAC BIOTECH LTD shareholders